Recruiting
Who we are
The Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in MSS Oligometastatic Colorectal Cancer
CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy
A Phase I/II Study With BM7PE Immunotoxin in Colorectal Cancer Patients
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Impact of Using the Oncogramme(R) Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Cancer
REGN7075 in Combination With Cemiplimab in Adult Participants With Advanced Solid Tumors
Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
A Study of NX-1607 in Adults With Advanced Malignancies
